D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
about
GPR158/179 regulate G protein signaling by controlling localization and activity of the RGS7 complexesType 5 G protein beta subunit (Gbeta5) controls the interaction of regulator of G protein signaling 9 (RGS9) with membrane anchorsRGS9-2: probing an intracellular modulator of behavior as a drug target.The R7 RGS protein family: multi-subunit regulators of neuronal G protein signalingMotor coordination deficits in mice lacking RGS9Functional comparison of RGS9 splice isoforms in a living cellEvidence for the involvement of ERbeta and RGS9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behaviorTargeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.Crystal structure of the multifunctional Gβ5–RGS9 complexX-ray structure of the mammalian GIRK2–βγ G-protein complexR7BP augments the function of RGS7*Gbeta5 complexes by a plasma membrane-targeting mechanismR7BP complexes with RGS9-2 and RGS7 in the striatum differentially control motor learning and locomotor responses to cocaineD1 dopamine receptor signaling is modulated by the R7 RGS protein EAT-16 and the R7 binding protein RSBP-1 in Caenoerhabditis elegans motor neuronsAdaptive gene regulation in the Striatum of RGS9-deficient miceG protein beta 5 is targeted to D2-dopamine receptor-containing biochemical compartments and blocks dopamine-dependent receptor internalizationAssociation between regulator of G protein signaling 9-2 and body weightGenomic survey of prepulse inhibition in mouse chromosome substitution strains.Norepinephrine loss produces more profound motor deficits than MPTP treatment in miceChronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.Direct spatial control of Epac1 by cyclic AMP.Regulator of G protein signaling 6 (RGS6) protein ensures coordination of motor movement by modulating GABAB receptor signaling.Photophobia and abnormally sustained pupil responses in a mouse model of bradyopsia.Transcriptomic and proteomic analyses of seasonal photoperiodism in the pea aphid.Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood.N-methyl-D-aspartic acid receptors on striatal neurons are essential for cocaine cue reactivity in miceRGS7 and -11 complexes accelerate the ON-bipolar cell light response.RGS9 knockout causes a short delay in light responses of ON-bipolar cells.Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease.Differential effects of the Gβ5-RGS7 complex on muscarinic M3 receptor-induced Ca2+ influx and release.cAMP regulates DEP domain-mediated binding of the guanine nucleotide exchange factor Epac1 to phosphatidic acid at the plasma membraneReversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay.Regulator of G protein signaling 6 is a critical mediator of both reward-related behavioral and pathological responses to alcoholRegulator of G protein signaling 9-2 (RGS9-2) mRNA is up regulated during neuronal differentiation of mouse embryonic stem cells.β-arrestin2 plays permissive roles in the inhibitory activities of RGS9-2 on G protein-coupled receptors by maintaining RGS9-2 in the open conformation.D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions.How regulators of G protein signaling achieve selective regulation.Gβ5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems.R7BP modulates opiate analgesia and tolerance but not withdrawal.RGS9-2--controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states.Subcellular localization of regulator of G protein signaling RGS7 complex in neurons and transfected cells.
P2860
Q24605032-47A710FF-BDDE-4E24-8966-7B4AA68DBB19Q24606708-54B5FF08-AED9-4B87-BDFA-B8EEB86C0309Q24632848-3CD70641-298D-49C1-A9E2-CEFB1462903DQ24643521-32C1CB48-1381-4E40-85BB-A84D3A7F21AFQ24648527-67956C96-AC55-47F9-9DEB-33D9C1B63E02Q24658414-BC196DEE-6E6C-4498-A5C3-8A15B6C24C2CQ24685456-EB8F2861-4059-46EE-9102-D044B89FA186Q27324174-C3AD6DF7-5298-4465-ADEB-C2D70BBE35E1Q27649555-5DEBBCA4-4259-48FA-900F-FC220372B8BAQ27678502-E31D3379-0F6B-4ED5-9D02-D34B2DE6103EQ28254091-71CF1472-9F5E-472E-B23F-B97FCD97143EQ28396194-B0D445FC-32D8-461E-A4EA-24B66514FA11Q28483848-F17E8573-76DE-4C11-96CC-873F0414FE0CQ28541409-FDE0CB6E-395A-4632-80BF-5A0A07C119A6Q28542580-71755EFF-521A-4EFB-85D4-7DF8481496C0Q28742338-256A30DE-DF93-474C-97E0-C3FE4B36217EQ30450693-4B9B308A-F515-4682-9D72-D49939758B60Q30479999-39FEC0D6-46E3-4422-A03B-F1D2F8AA582BQ30484170-B8CE2964-A163-486B-B108-C0FD83414D86Q30487622-8347F5A4-6C04-40AC-A3CC-083B7FD347F9Q30505394-E7746AC2-FAE2-43FF-949C-4FC74141FFB7Q30596574-2CF26800-6CD1-40B3-9544-905BD16EF79EQ33507446-0B5E4809-40D2-4DE8-B3FD-4473EDFDD5D2Q33651050-1C8C61DB-42A3-4B8A-B845-199D667DA988Q33771021-73F02A00-FCBF-4919-8749-7104482A59D7Q33845400-5F23A7E3-18EC-4C4B-923A-47433B1BD9E9Q34077964-13AB1341-F803-47D9-B679-5E80E0B976A1Q34105586-37A7082A-36D9-4EAA-AA1D-FD6FA059DDE3Q34219347-C8124EBA-E7B3-4293-88A4-2542EDF15907Q34255171-402C74A3-0045-4C0E-8C3A-9B29C01CFE03Q34991036-9E1EEE2C-4411-483A-911B-7837646D13FAQ35129073-EE77C438-C628-49CC-A988-44A5F606BBB1Q35540464-72771B1D-096B-4008-8AB3-CD571A780203Q35599100-56016CBF-E763-4037-97C0-8A8702CDD089Q35618940-8A3A5E22-0E02-4559-A7B9-4F3B248B2214Q35652043-66C1DF77-BB00-406B-A1C0-EDC145D82B4CQ35678190-7F3A0B78-ADF9-47DE-AC17-E4163C561A32Q35760250-6BFE1BFB-A570-4577-9B70-7278655DC61CQ36056818-F0F3F695-684F-4308-81E5-7C9B45C3BB39Q36087249-BA3D3994-0F07-489B-B2FD-D3F87F9E6AF8
P2860
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
D2 dopamine receptors colocali ...... ciated with dopamine pathways.
@ast
D2 dopamine receptors colocali ...... ciated with dopamine pathways.
@en
D2 dopamine receptors colocali ...... ciated with dopamine pathways.
@nl
type
label
D2 dopamine receptors colocali ...... ciated with dopamine pathways.
@ast
D2 dopamine receptors colocali ...... ciated with dopamine pathways.
@en
D2 dopamine receptors colocali ...... ciated with dopamine pathways.
@nl
prefLabel
D2 dopamine receptors colocali ...... ciated with dopamine pathways.
@ast
D2 dopamine receptors colocali ...... ciated with dopamine pathways.
@en
D2 dopamine receptors colocali ...... ciated with dopamine pathways.
@nl
P2093
P1476
D2 dopamine receptors colocali ...... ociated with dopamine pathways
@en
P2093
Abraham Kovoor
Benjamin N R Cheyette
Ching-Kang Chen
Jana Ebert
Johannes Schwarz
Melvin I Simon
Petra Seyffarth
Sami Barghshoon
Sigrid Schwarz
P304
P356
10.1523/JNEUROSCI.2840-04.2005
P407
P577
2005-02-01T00:00:00Z